Advertisement

Ira Jacobson, MD

Articles

Advertisement

Thoughts on the Current State of PBC Management

December 23, 2024

The panel of experts offers expert insights and concluding thoughts on the management of primary biliary cholangitis (PBC), emphasizing the importance of personalized treatment strategies, monitoring, and the evolving role of new therapies in improving patient outcomes.

Outcomes and Adoption of PPAR Agonists in PBC

December 23, 2024

The panel of experts addresses potential challenges in the adoption of peroxisome proliferator-activated receptor (PPAR) agonists for primary biliary cholangitis (PBC), including barriers to access, patient selection, and long-term treatment considerations.

Integration of PPAR Agonists in Treatment Landscape of PBC

December 18, 2024

The panel of experts explore the potential integration of peroxisome proliferator-activated receptor (PPAR) agonists into the current treatment landscape for primary biliary cholangitis (PBC) and provides recommendations for patients currently taking fibrates for managing the disease.

Advertisement
Advertisement
Advertisement
x